Mecocorn-P Tablet contains Pregabalin 75mg, an anticonvulsant and neuropathic pain agent primarily used in the management of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and spinal cord injury. It is also indicated as adjunctive therapy for partial-onset seizures in adults. Pregabalin acts by binding to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, thereby reducing the release of excitatory neurotransmitters and modulating neuronal excitability. Mecocorn-P is effective in alleviating symptoms such as burning, shooting pain, and allodynia. The tablet is typically administered orally, with dosing individualized based on patient response and tolerability. Common side effects include dizziness, somnolence, dry mouth, and weight gain, while serious adverse reactions are rare but may include hypersensitivity and angioedema. Caution is advised in patients with renal impairment, and dose adjustments may be necessary. Mecocorn-P should be used under medical supervision, particularly in individuals with a history of substance abuse or psychiatric disorders, due to potential risks of misuse and mood alterations. This medication should not be abruptly discontinued to avoid withdrawal symptoms. Overall, Mecocorn-P Tablet offers an effective therapeutic option for managing neuropathic pain and seizure disorders.